Edesa Biotech
EDSA
11 hedge funds and large institutions have $1.22M invested in Edesa Biotech in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1,411% more capital invested
Capital invested by funds: $81K → $1.22M (+$1.14M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
0.2% more ownership
Funds ownership: 0.03% → 0.23% (+0.2%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$819K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$106K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.9K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$49K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
1
FNY Investment Advisers
New York
| $971K | +$819K | +17,201 | New |
|
|
2
Stifel Financial
St. Louis,
Missouri
| $126K | +$106K | +2,232 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $90K | +$75.9K | +1,596 | New |
|
|
BBA
4
Braun-Bostich & Associates
Canonsburg,
Pennsylvania
| $25K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | -$12.8K | -270 | -59% |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
CS
7
Credit Suisse
Zurich,
Switzerland
| – | -$49K | -1,429 | Closed |
|
|
8
Wells Fargo
San Francisco,
California
| – | +$48 | +1 | +50% |
|
EDSA Hedge Fund Activity: Q3 2020 in Review
11 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2020, worth a combined $1.22M — up 1,411% from $81K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $819K. The largest seller was Credit Suisse, exiting entirely with an estimated $49K sold.
- 11 institutional investors held Edesa Biotech (EDSA) as of Q3 2020, up from 10 in Q2 2020.
- Funds reported $1.22M of Edesa Biotech stock for Q3 2020, up 1,411% quarter-over-quarter.
- 3 funds opened new Edesa Biotech positions in Q3 2020 and 2 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q3 2020 was FNY Investment Advisers, an estimated $819K added.
- The largest Edesa Biotech seller in Q3 2020 was Credit Suisse, an estimated $49K sold.
Based on aggregated 13F filings for Q3 2020.